Sarepta Therapeutics (SRPT) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278.97% |
| Dec 31, 2025 | 88.16% |
| Sep 30, 2025 | -62.92% |
| Jun 30, 2025 | 131.29% |
| Mar 31, 2025 | -195.25% |
| Dec 31, 2024 | 587.25% |
| Sep 30, 2024 | -325.41% |
| Jun 30, 2024 | -3,730.53% |
| Mar 31, 2024 | 99.03% |
| Dec 31, 2023 | 62.22% |
| Sep 30, 2023 | -1,469.85% |
| Jun 30, 2023 | 79.25% |
| Mar 31, 2023 | -32.38% |
| Dec 31, 2022 | -142.12% |
| Sep 30, 2022 | 147.85% |
| Jun 30, 2022 | 59.58% |
| Mar 31, 2022 | -270.48% |
| Dec 31, 2021 | 627.03% |
| Sep 30, 2021 | -145.56% |
| Jun 30, 2021 | 1,135.17% |
| Mar 31, 2021 | -173.00% |
| Dec 31, 2020 | 117.25% |
| Sep 30, 2020 | -33.05% |
| Jun 30, 2020 | -113.37% |
| Mar 31, 2020 | 742.74% |
| Dec 31, 2019 | 231.79% |
| Sep 30, 2019 | -205.02% |
| Jun 30, 2019 | -78.27% |
| Mar 31, 2019 | 127.50% |
| Dec 31, 2018 | 180.29% |
| Sep 30, 2018 | -36.52% |
| Jun 30, 2018 | -246.22% |
| Mar 31, 2018 | -136.66% |
| Dec 31, 2017 | -103.99% |
| Sep 30, 2017 | 522.36% |
| Jun 30, 2017 | -169.84% |
| Mar 31, 2017 | 155.85% |
| Dec 31, 2016 | -196.26% |
| Sep 30, 2016 | 283.81% |
| Jun 30, 2016 | 274.50% |
| Mar 31, 2016 | -272.77% |
| Dec 31, 2015 | 278.48% |
| Sep 30, 2015 | -180.09% |
| Jun 30, 2015 | -653.45% |
| Mar 31, 2015 | -95.84% |
| Dec 31, 2014 | 142.12% |
| Sep 30, 2014 | -194.04% |
| Jun 30, 2014 | 125.81% |
| Mar 31, 2014 | -1,146.26% |
| Dec 31, 2013 | -114.20% |
| Sep 30, 2013 | 1,101.01% |
| Jun 30, 2013 | 40.56% |
| Mar 31, 2013 | -113.19% |
| Dec 31, 2012 | 1,009.02% |
| Sep 30, 2012 | 321.90% |
| Jun 30, 2012 | 34.82% |
| Mar 31, 2012 | -44.62% |
| Dec 31, 2011 | 17.62% |
| Sep 30, 2011 | -125.34% |
| Jun 30, 2011 | 399.87% |
| Mar 31, 2011 | -333.39% |
| Dec 31, 2010 | -206.84% |